AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Insmed Inc. Surges to All-Time High on Optimistic Outlook
ByAinvest
Friday, Oct 31, 2025 10:08 am ET1min read
Insmed Inc. (NASDAQ:INSM) reached an all-time high after posting a highly optimistic outlook for the full-year period, despite a widening net loss in Q3. The company expects global revenues from Arikayce to grow between 15-18% to $420-$430 million, up from a previous projection of $405-$425 million. Revenues from Arikayce grew 22% YoY to $114.3 million, and Brinspuri generated $28.1 million in revenues during the quarter. The stock soared 16.33% to $194.22 per share.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet